Xchange — 16 new programmes added to online registry of evidence-based prevention programmes

The EMCDDA has added 16 new programmes to Xchange, its online registry of evidence-based prevention programmes. Launched in October 2017, and now ending its pilot phase, the registry showcases interventions that European evaluation studies demonstrate to have promising outcomes relating to substance use. Five of the new programmes focus on substance use prevention and 11 on crime and delinquency prevention. At present, Xchange contains 38 programmes. 22.02.2019 
Čtěte více

EMCDDA intensifies its cooperation with the European Neighbourhood Policy countries

This year, the EMCDDA has launched a three-year project — EU4Monitoring Drugs (EU4MD) — which will intensify its cooperation with the countries of the European Neighbourhood Policy (ENP)(1)(2). The EU-funded project, running until the end of 2021, will support national and regional readiness in the ENP area to identify and respond to drug-related health and security threats. 21.02.2019 
Čtěte více

EMCDDA signs two new working arrangements with ECHA and EFSA

Two new working arrangements will be signed in Brussels today between the EMCDDA and the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA). The EMCDDA will now be cooperating with five EU agencies under new legislation applying from 23 November 2018, which strengthens the EU Early Warning System on new psychoactive substances (1). Three existing working arrangements with the European Centre for Disease Prevention and Control (ECDC); the European Medicines Agency (EMA) and Europol were updated and signed in December 2018 (2). 12.02.2019 
Čtěte více

I nadále prosíme odborníky o spolupráci v rámci systému včasného varování před novými drogami - NOVÉ DROGY - JAK POSTUPOVAT

Celonárodní studie mapující fenomén užívání psychedelických látek a konopí v ČR (tzv. národní psychedelický výzkum) probíhá na stránce psychedelickyvyzkum.cz